MED 6788. DERMATOLOGY & MUSCULOSKELETAL SYSTEMS: SYLLABUS

COURSE OBJECTIVES
This course is a brief (three-week) overview of the most common diseases affecting the skin, muscles, bones and joints. It consists of a combination of didactic and problem-based learning (PBL) encounters designed to provide the student with a basic understanding of the pathophysiology, etiology and clinical presentation of a wide variety of infectious, traumatic, genetic, degenerative, vascular, immunologic and neoplastic diseases. The course is divided into two sections: the first two weeks covering diseases of the skin and the last two weeks covering diseases of muscle, bones and joints. The student is expected to review the normal anatomy and histology of each region covered, while special lectures will provide reviews of
the physiology of the integument and neuromuscular junction. Keep in mind that learning objectives include the normal anatomy, histology and physiology of the dermatomusculoskeletal system. While much of the subject matter in this course is presented by clinicians, the learning objectives stress the pathophysiology of the diseases presented. It is important for the student to
recognize that many diseases with widely divergent clinical presentations have common pathophysiologic mechanisms, and conversely, that many diseases with similar clinical presentations have different etiologies as well as mechanisms.

For each disease entity discussed the student should keep in mind the:
1. Clinical Presentation
2. Diagnosis (including Physical Findings, Laboratory and Imaging Data)
3. Etiology
4. Pathophysiology
5. Prognosis
6. Treatment and Pharmacology (drug mechanism)

PBL cases have been selected to cover material not necessarily covered in the didactic portion of the course. Students are expected to utilize all resources available in PBL sessions to cover the material at an appropriate level, i.e., to gain a thorough understanding of the diseases involved in the given clinical presentation including a detailed understanding of possible etiologies and pathophysiologic mechanisms of each entity.

EXAMINATION
Examinations: Examination questions will cover all aspects of the course material covered and will be comprehensive. Questions may not be asked on all material covered, and tests may be weighted unequally at the discretion of the faculty and course director. This is done in an attempt to encourage students to study all of the material presented, regardless of its time allotment in the curriculum. Approximately 20% of the questions should be of an integrated nature incorporating physiology, pathology, pharmacology and clinical medicine. Examination I (mid-block exam) will be given on 6/15/04 (Tuesday) from 8:00-10:00 a.m.. This will be a computerized exam totaling 100 points and will cover material presented through 6/14/02
and count for 1/3 of the final grade. Examination II (final examination) will be given on 6/25/04 (Friday) from 8:00 a.m.-11:00. This will be a computerized exam totaling 200 points, comprehensive, and count 2/3 of the final point
total.

DERMATOMUSCULOSKELETAL GRADING POLICY
2
O: = or > 1.3 STD above the mean
E: = or greater than .2 STD above the mean but < 1.3 STD above the mean
S: = or > 1.6 STD below the mean to .2 STD above the mean, or at least 70%
For all three grades above, the student also needs to receive a grade of “P” from your PBL
instructor
N: < 1.6 STD below the mean
A grade of I will be given if a student has not completed all course assignments or examinations.
Students receiving a grade of N will be allowed to take a makeup exam. The score from this exam
will be averaged with the two previous exam scores to provide a cumulative average, which must be
70% or greater for the student to receive an S. If the student still has an N following this exam, the
course must be repeated.

COURSE TEXTBOOKS
1. Bates B. 2003. A Guide to Physical Examination and History Taking. 8th Edition. J.B. Lippincott.
2. Cotran, Kumar & Collins. 1999. Robbins Pathological Basis of Disease. 6th Edition. Philadelphia: Saunders.
3. Katzung BG. 2001/2003. Basic and Clinical Pharmacology. 8th/9th Edition. Norwalk: Appleton & Lange.
4. Schaechter, M. et al. 1999. Mechanisms of Microbial Disease. 3rd Edition. Baltimore Lippincott Williams & Wilkins
5. Klippel J. 1997. Primer on the Rheumatic Diseases. 11th Edition. Arthritis Foundation.
6. Moore KL. 1992. Clinically Oriented Anatomy. 3rd Edition. Baltimore: Williams & Wilkins.
7. Rubin RH. 1996. Medicine: A Primary Care Approach. Philadelphia: W.B. Saunders.
8. Sloane PD. 2002. Essentials of Family Medicine. 4th Edition. Baltimore: Williams & Wilkins.
9. Salter RB. 1999. Textbook of Disorders and Injuries of the Musculoskeletal System. 3rd Edition. Baltimore: Williams & Wilkins.
10. McCullough J. 1997. MacNab's Backache. 3rd Edition. Lippincott.
11. Berkowitz CD. 1996. Pediatrics: A Primary Care Approach. Philadelphia: Saunders.
12. CD ROM version of: Color Atlas and Synopsis of Clinical Dermatology/Thomas B. Fitzpatrick et al., Third Edition, 1997. New York: McGraw-Hill. 3

COURSE FACULTY
Dr. James Anderson Family Medicine janders1
Dr. Susan Ash SMDC/Dermatology
Dr. Johan Bakken St. Luke's Infections Disease
Dr. Michael Bayer SMDC/Dermatology
Dr. Jay Butcher SMDC/Sports Medicine
Dr. Jeffrey Evanson Family Medicine
Dr. Ana Fernandez SMDC/Rheumatology
Dr. Kent Froberg Pathology & Laboratory Medicine 726-7223 kfroberg
Dr. Craig Gilbertson Family Medicine
Dr. Douglas Hoffman SMDC
Dr. David Leuhr Cloquet Clinic
Dr. Sarah Lundeen St. Luke's Hospital/Pathology
Dr. Robert Lund SMDC/Dermatology
Dr. Andrew Messa Family Medicine
Dr. Glenn Nordehn Family Medicine 726-7564 gnordeh1
Dr. Jean Regal Pharmacology 726-8950 jregal
Dr. Sarah Siedelmann SMDC/Pathology
Dr. Thomas Silvestrini Family Medicine
Dr. David Spoelhof Family Medicine
Dr. George Trachte Pharmacology 726-8975 gtracht1
Dr. Daniel Vandersteen SMDC/Pathology 726-7911
Dr. Ruth Westra Family Medicine 726-8393 rwestra
Dr. Geoffrey Witrak SMDC/Pathology 726-7911
Dr. Lorentz Wittmers Medical & Molecular Physiology 726-7934 lwittmer
Dr. Richard Ziegler Medical Microbiology & Immunology 726-7280 rziegler
*Note: If you have questions regarding clinical lecturers, please contact Dr. Ruth Westra, Family
Medicine Course Director (x7574) or Jan Pierce (x7802).

STUDENT EVALUATION OF THE COURSE
Your input relative to the course is actively solicited by the course faculty and will be reviewed by the Office of Curricular Affairs and the Education Policy Committee. Upon completion of the course, the Evaluation of the Course form will be distributed and collected by the Office of Curricular Affairs; the Evaluation of Instructor form will be distributed and collected by the Course Director. In both cases, your responses are anonymous unless you choose to identify yourself. We encourage your thoughtful attention to this input since it is considered carefully in planning the course for the subsequent year.

SPECIAL STUDENT NEEDS
Accommodations can be made for students with special needs. Requests are handled by Dr. Repesh’s office. The Course Faculty will make every effort to accommodate the needs of all such students as identified by the Office of Student Affairs. It remains the obligation of the student to make sure individual faculty are apprised of his/her individual student needs and that all accommodations requested are utilized.